Preventive Asthma Drugs Market Report Projection - Trends and Forecast 2017 - 2025

Asthma is a chronic inflammatory disease of the airways caused by recurrent attacks of breathlessness, bronchospasm, and reversible airflow obstruction. Asthma is a life threatening lung disease that hinders normal breathing. It has become one of the most common diseases that affects quality life of patients. It has been anticipated by the physicians the cases for asthma and COPD are increasing on a magnificent level. An estimated 300 million people suffer from asthma globally, with around 250,000 deaths each year. According to the American Academy of Allergy, Asthma, and Immunology, asthma can be classified into four types: exercise-induced, occupational, childhood, and allergic. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic and non-allergic. Asthma can be controlled by preventive medicines, which ought to be managed to the patient regularly to enhance his quality of life by controlling the frequency and intensification of asthmatic attacks. Occurrence of asthma is common in both genders owing to increased usage of tobacco and exposure to smoke of biomass fuels used for cooking.

Request for sample copy of this report : https://www.marketresearchreports.biz/sample/sample/1381716

Increase in incidence of asthma and rise in industrialization leading to high air pollution are the major factors anticipated to drive the global preventive asthma drugs market. Asthma is a well-recognized disorder. Hence, simple diagnostic tests such as spirometry, polysomnography devices, peak flow meters, and other diagnostic devices are available in the market. Several drugs are also available in the market for the treatment of asthma including Advair and Pulmicort. Unknown disease etiology is the major restraint of the market.

The global preventive asthma drugs market can be segmented based on product type and application. In terms of product type, the market can be segmented into immunosuppressants, corticosteroids, combination of LABA/ICS, leukotriene antagonists, and mast cell stabilizers. Corticosteroids are projected to account for the largest share of the market. The most commonly prescribed corticosteroids are Seretide/Advair and Flixotide/Flovent. Based on application, the global preventive asthma drugs market can be segmented into children and adults.

View Full Report : https://www.marketresearchreports.biz/reports/1381716/preventive-asthma-drugs-global-market-research-reports

Geographically, the global preventive asthma drugs market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global market, followed by Europe, due to increased awareness among people and well developed medical system. However, the market in Asia Pacific is expected to grow at a rapid pace during the forecast period owing to increase in incidence of asthma and adoption of modern lifestyles. Additionally, increase in number of contract manufacturing organizations in Asia Pacific drives the preventive asthma drugs market in the region. According to the WHO, regions such as Southeast Asia and Africa have highest mortality rates and high demand for asthma preventive medicines as some of the countries in these regions have less access to essential medicines. Lack of manufacturing facilities, technologies, and high dependence on imports are the factors hampering the growth of the preventive asthma drugs market in these regions.

Key players in the global preventive asthma drugs market include Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Merck & Co., F. Hoffmann-La Roche, Abbott Laboratories, Boehringer Ingelheim, MediciNova, Inc. and Mylan.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players
Emerging niche segments and regional markets
An objective assessment of the trajectory of the market
Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

MRRbiz supports your business intelligence needs with over 700,000 market research reports, company profiles, data books, and regional market data sheets in its repository. Our document database is updated by the hour, which means that you always have access to fresh data spanning over 300 industries and their sub-segments.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
(USA-Canada)

Tel: +1-518-621-2074
E: sales@marketresearchreports.biz

This release was published on openPR.